Evidence map›Paper›PMID 27802159›Full record

ArticleJournal of cell science2016

Phosphorylation of STAT2 on serine-734 negatively regulates the IFN-α-induced antiviral response.

Håkan C Steen, Kevin P Kotredes, Shoko Nogusa, Michele Y Harris, Siddharth Balachandran, Ana M Gamero

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Exposing the Two Contrasting Faces of STAT2 in Inflammation.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Håkan C SteenDept. of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Kevin P KotredesDept. of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Shoko NogusaImmune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Michele Y HarrisDept. of Anatomy and Cell Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Siddharth BalachandranImmune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Ana M GameroDept. of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA gameroa@temple.edu.ORCID 0000-0001-7843-1415
Temple University · USFox Chase Cancer Center · US

Funding

Crosstalk between STAT2 and Bim in type I IFN SignalingR01CA140499 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI GAMERO, ANA M · 2009 to 2013
$1.4M
A Critical Role for Stat2 in Type 1 Intferon-Induced ApoptosisK22CA095326 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI GAMERO, ANA M · 2008 to 2009
$323k
NCI NIH HHS K22 CA095326NCI NIH HHS R01 CA140499
6 · The paper itself

Abstract

Serine phosphorylation of STAT proteins is an important post-translational modification event that, in addition to tyrosine phosphorylation, is required for strong transcriptional activity. However, we recently showed that phosphorylation of STAT2 on S287 induced by type I interferons (IFN-α and IFN-β), evoked the opposite effect. S287-STAT2 phosphorylation inhibited the biological effects of IFN-α. We now report the identification and characterization of S734 on the C-terminal transactivation domain of STAT2 as a new phosphorylation site that can be induced by type I IFNs. IFN-α-induced S734-STAT2 phosphorylation displayed different kinetics to that of tyrosine phosphorylation. S734-STAT2 phosphorylation was dependent on STAT2 tyrosine phosphorylation and JAK1 kinase activity. Mutation of S734-STAT2 to alanine (S734A) enhanced IFN-α-driven antiviral responses compared to those driven by wild-type STAT2. Furthermore, DNA microarray analysis demonstrated that a small subset of type I IFN stimulated genes (ISGs) was induced more by IFNα in cells expressing S734A-STAT2 when compared to wild-type STAT2. Taken together, these studies identify phosphorylation of S734-STAT2 as a new regulatory mechanism that negatively controls the type I IFN-antiviral response by limiting the expression of a select subset of antiviral ISGs.

Indexed as

Amino Acid SequenceAnimalsAntiviral AgentsCell LineCell ProliferationHumansInterferon-alphaJanus KinasesMass SpectrometryMiceModels, BiologicalPhosphorylationSerineSTAT2 Transcription FactorSubcellular FractionsVesiculovirusAntiviral AgentsInterferon-alphaJanus KinasesSerineSTAT2 Transcription FactorInterferonJAK1Serine phosphorylationSTAT2Vesicular stomatitisVirus infection

Identifiers

PMID27802159
PMCPMC6518330
OpenAlexW2537296941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.